Fulvestrant / FASLODEX

• Product NameFulvestrant / FASLODEX
  CAS No.129453-61-8
  Purity
  Min Quantity100Kilograms
  Price1000~
• View Contact Detail

• 
  Molecular Structure

Detailed Description

Fulvestrant / FASLODEX
Chemical Name:(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol
CAS:129453-61-8
Density:1.201 g/cm3
Melting Point:104-106°C
Boiling Point:674.8 °C at 760 mmHg
Molecular Fomular:C32H47F5O3S
Molecular Weight:606.77
Appearance:white powder
Usage:Antineoplastic (hormonal)
Packing: foil bag
Payment: Bank Transfer, Western Union, Money Gram
Express: EMS, DHL, FedEx, etc(door-to-door)
Delivery: Safe & timely, around 1-3 days after payment

Applications:
Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.
Fulvestrant Acetate (Faslodex, AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.
Fulvestrant Acetate is a selective estrogen receptor down-regulator (SERD). Fulvestrant is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. The dosing schedule for fulvestrant remains under investigation in an attempt to optimize its effectiveness.

ycgl01@yccreate.com
skype: echo01_5
Tel:18188938036
http://www.sellsteroids.com

• 
• Fulvestrant / FASLODEX